Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by floatinketuckyon Apr 28, 2021 8:13am
254 Views
Post# 33080934

RE:Patient #16, #17 & #18

RE:Patient #16, #17 & #18The confusion is enginered by resident bashers. Who like to state half the facts and post without supporting links....     Look at I-Hub. Post 3941

They are some tricky players hoping to knock shares out of weak hands. 

We know that they understand the rates.

99942Apophis wrote: Three patients #16, #17 &#18 have not reached their 90 day period and therefore fall into the category of "Pending " this could be where some newer investors are confused, newer investors might be taking this term "Pending" as if something has gone wrong but everything is ok and once 16  17 & 18 reach the 90 day period then they will qualify for full CR (Complete Response) which under current optimized treatment will happen in my biased opinion ( thumbs up )



<< Previous
Bullboard Posts
Next >>